Opdualag

(nivolumab / relatlimab)
Opdualag 240 MG / 80 MG in 20 ML Injection
NO BOXED WARNING

Dosage & administration

drug label

Opdualag prescribing information

prior authorization

Opdualag prior authorization resources

Most recent Opdualag prior authorization forms

View By Payer
Verified: Apr 07, 2024Kaiser Foundation Health Plan - Chronic High-Dose Opioid Therapy Prior Authorization Form Washington
Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Medicare Prescription Drug Medication Request Form
Verified: Apr 01, 2024Highmark BCBS Northeastern NY - Short Acting Opioid Prior Authorization Form
Verified: Apr 01, 2024Highmark BCBS Western NY - Specialty Drug Prior Authorization Form
Verified: Apr 01, 2024Highmark BCBS Western NY - Non-Formulary Drug Coverage Prior Authorization Form

Most recent state uniform prior authorization forms

Verified: Mar 28, 2024Arizona - Uniform Prior Authorization Form
Verified: Mar 28, 2024Colorado - Uniform Prior Authorization Form
Verified: Mar 28, 2024Hawaii - Uniform Prior Authorization Form
Verified: Mar 28, 2024Illinois - Uniform Prior Authorization Form
Verified: Mar 28, 2024Indiana - Uniform Prior Authorization Form
Verified: Mar 28, 2024Louisiana - Uniform Prior Authorization Form
Verified: Mar 28, 2024Minnesota - Uniform Prior Authorization Form
Verified: Mar 28, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Mar 28, 2024New Mexico - Uniform Prior Authorization Form
Verified: Mar 28, 2024Oregon - Uniform Prior Authorization Form
Verified: Mar 28, 2024Texas - Uniform Prior Authorization Form
Complete Letter of Medical Necessity
Coverage Authorization Appeals
Commercial Claim Denial Appeal/Redetermination Letter
Medically Unlikely Edit (MUE) Appeal Letter
Learn More

Benefits investigation

Opdualag Enrollment Form
Opdualag Enrollment Form - Spanish
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

Financial Assistance

Financial Assistance Programs

Opdualag retails for $766 per dose without insurance or financial assistance.Depending on your patient's insurance situation and other eligibility criteria, they may be able to get Opdualag for significantly less. Review the program information below to determine what program can offer your patient the most benefits.
CoPay Card Program$0 Co Pay
Available for
commercial
Program Details
  • Program Expires Calendar Year
Forms
Opdualag Enrollment Form
Opdualag Enrollment Form - Spanish
Enroll in Patient Savings Program

PubMed™ | Opdualag

Opdualag PubMed™ News

patient education

Opdualag patient education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

About Opdualag
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Receiving Opdualag
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Infusion Tips Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Doctor Discussion Guide
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effect Tracker
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Caregiver Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Opdualag FAQs

How is the dosage of Opdualag?Opdualag is available in 1 dosages, including 12-4 mg/ml Injection 20 ml
What does Opdualag treat?Opdualag treats Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms, Lymphoma and Melanoma
What is Opdualag made of?Opdualag contains nivolumab / relatlimab which is a Programmed Death Receptor-1 Blocking Antibody
How Is Opdualag Administered?Opdualag is administered as a Injectable
What Are The Opdualag Mechanism Of Action?Opdualag mechanism of action is Programmed Death Receptor-1-directed Antibody Interactions
FAQ Data Source